Incyte (INCY) Current Assets (2010 - 2026)
Incyte (INCY) reported Current Assets of $5.5 billion for Q1 2026, up 56.36% on a YoY basis from $3.5 billion in Q1 2025, and up 9.16% quarter-over-quarter from $5.0 billion in Q4 2025.
Incyte (INCY) Current Assets (2010 - 2026) Analysis & Trends
Incyte has reported Current Assets for 17 years, with the latest figure at $5.5 billion in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 56.36% year-over-year to $5.5 billion; the trailing twelve-month figure through Mar 2026 stood at $5.5 billion (up 56.36% YoY), and the FY2025 full-year result was $5.0 billion, up 55.11% from the prior year.
- Current Assets for Q1 2026 stood at $5.5 billion, up from $5.0 billion in the prior quarter.
- The five-year high for Current Assets was $5.5 billion in Q1 2026, with the low at $2.6 billion in Q2 2024.
- Historically, Current Assets has averaged $4.0 billion across 5 years, with a median of $4.0 billion in 2023.
- Annual changes were most pronounced in 2024 — Current Assets slumped 39.8% — and 2026, when it jumped 56.36%.
- Incyte's Current Assets stood at $4.1 billion in 2022, then grew by 13.5% to $4.6 billion in 2023, then slumped by 30.27% to $3.2 billion in 2024, then soared by 55.11% to $5.0 billion in 2025, then increased by 9.16% to $5.5 billion in 2026.
- The last three Current Assets figures came in at $5.5 billion (Q1 2026), $5.0 billion (Q4 2025), and $4.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 5.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.48 Bn |
| Dec 31, 2025 | 5.02 Bn |
| Sep 30, 2025 | 4.28 Bn |
| Jun 30, 2025 | 3.64 Bn |
| Mar 31, 2025 | 3.51 Bn |
| Dec 31, 2024 | 3.24 Bn |
| Sep 30, 2024 | 2.81 Bn |
| Jun 30, 2024 | 2.57 Bn |
| Mar 31, 2024 | 4.85 Bn |
| Dec 31, 2023 | 4.65 Bn |
| Sep 30, 2023 | 4.40 Bn |
| Jun 30, 2023 | 4.26 Bn |
| Mar 31, 2023 | 3.97 Bn |
| Dec 31, 2022 | 4.09 Bn |
| Sep 30, 2022 | 3.82 Bn |
| Jun 30, 2022 | 3.63 Bn |
| Mar 31, 2022 | 3.29 Bn |
| Dec 31, 2021 | 3.12 Bn |
| Sep 30, 2021 | 2.92 Bn |
| Jun 30, 2021 | 2.62 Bn |